CClinicalTrials.gg
CompletedNCT06849726Updated Sep 1, 2026

Epidural vs. Dural Puncture Epidural in Labor Analgesia

An observational study in Labor Pain and Epidural Analgesia, sponsored by Medipol University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Medipol University · Observational

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
100
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Childbirth is an intense physical and psychological experience. Epidural analgesia (EP) remains the gold standard in labor pain management. However, continuous refinements are aimed at enhancing analgesic quality and mitigating adverse effects. In recent years, the dural puncture epidural (DPE) technique has gained popularity. In this technique, the dura is intentionally punctured with a spinal needle before the epidural catheter is placed, but no intrathecal medication is administered. This historically controlled study evaluates the clinical outcomes of a protocol transition from standard high-dose epidural to low-dose DPE. The primary objective is to compare total analgesic consumption and success rates of labor analgesia between the two techniques. The secondary objectives include the assessment of hemodynamic parameters, motor block characteristics, adverse effects (such as paresthesia and hypotension), and overall maternal satisfaction

Read the detailed description

The maternal pain experience encompasses psychological and emotional components, highlighting the necessity for patient-centered assessment approaches. While standard epidural and combined spinal-epidural (CSE) techniques are common, they carry risks such as inadequate sacral coverage, motor block, or fetal bradycardia. The dural puncture epidural (DPE) technique aims to combine the advantages of EP and CSE while minimizing their disadvantages. By creating a dural hole, DPE facilitates the translocation of epidural medications into the subarachnoid space, aiming to accelerate the onset of analgesia and improve block quality.This single-center, historically controlled study consists of two consecutive cohorts managed before and after a change in the clinical protocol. Group 1 (retrospective control) received standard concentration epidural analgesia. Group 2 (prospective intervention) received the low-dose DPE technique. The study hypothesizes that the low-dose DPE technique provides non-inferior analgesic efficacy with significantly reduced total bupivacaine consumption and a superior side-effect profile compared to the standard high-dose EP technique. Outcomes evaluated include total bupivacaine consumption, adequate analgesia success (NRS \< 4), maternal hemodynamic changes, incidence of adverse effects including paresthesia, and patient satisfaction. Note on outcome reporting: serial intrapartum measurements of maternal blood pressure, maternal heart rate and fetal heart rate were not documented on the routine anesthesia monitoring forms used during the retrospective control period. The registered secondary outcome of maternal hemodynamic and fetal heart rate variation could therefore not be compared between the two cohorts. Baseline values recorded before the procedure were available for all 100 participants and are reported as baseline characteristics, together with the incidence of hypotension and of fetal bradycardia. No registered outcome has been removed from this record.

02

Conditions studied

  • Labor Pain
  • Epidural Analgesia

Browse trials for

Keywords

  • Labor Analgesia
  • Epidural Analgesia
  • Dural Puncture Epidural
03

In context

Labor Pain

396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.

This study's enrollment of 100 is close to the median of 101 across 56 observational studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of healthy pregnant women (ASA physical status I-II) with a singleton pregnancy at 37-42 weeks of gestation, who planned a vaginal delivery and requested labor analgesia during active labor (cervical dilation ≥ 4 cm) at a single university hospital.

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I-II
  • Gestational age 37-42 weeks
  • Planned vaginal delivery
  • Request for labor analgesia during active labor with cervical dilation ≥ 4 cm

Exclusion criteria

Exclusion Criteria:

  • Multiple gestations
  • Diagnosis of preeclampsia/eclampsia
  • Severe systemic disease
  • Contraindications to epidural analgesia (e.g., coagulopathy, infection at the injection site)
  • History of opioid dependence
  • Refusal to participate in the study protocol
  • Missing data in medical records for the retrospective group
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Standard Epidural Analgesia

    Patients in this retrospective control group received the standard concentration epidural analgesia. Using an 18-G Tuohy needle, the epidural space was identified and a catheter was advanced. No dural puncture was performed. A loading dose consisting of 0.125% bupivacaine (25 mg) and fentanyl (40 µg) in a total volume of 20 mL was administered via the catheter.

    Procedure: Standard Epidural Analgesia

  • Dural Puncture Epidural (DPE) Analgesia

    Patients in this prospective intervention group received the low-dose DPE technique. After identifying the epidural space, the dura mater was punctured using a 27-G spinal needle until the clear return of cerebrospinal fluid was visualized. No intrathecal medication was administered, the spinal needle was withdrawn, and the epidural catheter was positioned. A loading dose consisting of 0.0625% bupivacaine (12.5 mg) and fentanyl (40 µg) in a total volume of 20 mL was applied.

    Procedure: Dural Puncture Epidural Analgesia

Interventions

  • ProcedureStandard Epidural Analgesia

    Administration of conventional epidural analgesia using an 18G Tuohy needle for catheter placement and subsequent administration of a standardized dose of bupivacaine with fentanyl.

  • ProcedureDural Puncture Epidural Analgesia

    Administration of epidural analgesia that incorporates a dural puncture with a 27G spinal needle prior to epidural catheter placement, followed by administration of a lower concentration of bupivacaine with the same dose of fentanyl.

06

What researchers measure

Primary outcomes

  1. Total Analgesic Consumption

    Cumulative bupivacaine consumption measured in milligrams.

    Time frame: From the initiation of epidural analgesia until delivery.

  2. Adequate Analgesia Achievement

    Proportion of participants achieving a target Numeric Rating Scale (NRS) score of less than 4

    Time frame: Assessed at 15 minutes post-procedure and during hourly follow-ups until delivery.

Secondary outcomes

  1. Incidence of Adverse Effects

    Recording of adverse effects including nausea, vomiting, pruritus, hypotension, and paresthesia

    Time frame: Continuously monitored from the initial epidural dose until delivery.

  2. Requirement for Supplemental Analgesia

    Total number of supplemental boluses required during labor

    Time frame: From the initiation of epidural analgesia until delivery.

  3. Maternal Satisfaction

    Documented patient satisfaction levels regarding the childbirth experience

    Time frame: Assessed in the early postpartum period.

  4. Post-Dural Puncture Headache

    Incidence and severity of post-dural puncture headache in the postpartum period.

    Time frame: Up to 1 week postpartum.

  5. Incidence and Severity of Motor Block

    Occurrence and degree of motor block, evaluated by the Modified Bromage Scale.

    Time frame: Monitored throughout the procedure until delivery.

  6. Maternal Hemodynamic and Fetal Heart Rate Variations

    Variation in maternal blood pressure, heart rate, and fetal heart rate changes.

    Time frame: Continuously monitored throughout the procedure.

07

Study locations

1 site
  • Medipol University
    Istanbul, Turkey (Türkiye)
08

References and documents

Publications

  • Lin W, Yang Y, Lin J, Chen J, Lin Q. Dural Puncture Epidural with 25-G Spinal Needles versus Conventional Epidural Technique in Conjunction with PIEB for Labor Analgesia: A Randomized Trial. J Pain Res. 2023 Nov 8;16:3797-3805. doi: 10.2147/JPR.S424082. eCollection 2023. PubMed 38026464 ↗
  • Song Y, Du W, Zhou S, Zhou Y, Yu Y, Xu Z, Liu Z. Effect of Dural Puncture Epidural Technique Combined With Programmed Intermittent Epidural Bolus on Labor Analgesia Onset and Maintenance: A Randomized Controlled Trial. Anesth Analg. 2021 Apr 1;132(4):971-978. doi: 10.1213/ANE.0000000000004768. PubMed 32282386 ↗
  • Wang J, Zhang L, Zheng L, Xiao P, Wang Y, Zhang L, Zhou M. A randomized trial of the dural puncture epidural technique combined with programmed intermittent epidural boluses for labor analgesia. Ann Palliat Med. 2021 Jan;10(1):404-414. doi: 10.21037/apm-20-2281. PubMed 33545772 ↗

Individual participant data

Plan to share: Yes — only IPD used in the results publication

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06849726
Lead sponsor
Medipol University
Responsible party
Burak Omur (Assistant Professor, Medipol University) — Principal investigator
First posted
Feb 27, 2025
Start date
Mar 10, 2025
Primary completion
Oct 20, 2025
Completion
Dec 20, 2025
Last update
Sep 1, 2026

Study contacts

Burak öMÜR
principal investigator · Medipol University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion